Jul 2026· Frontiers in Cellular and Infection Microbiology· Vol 16· 0 citations· 35 references
Medicine
TL;DR
The results highlight the potential of gut bacterial and viral biomarkers as candidate biomarkers and potential auxiliary tools for MDD assessment and suggest that integrating multi-domain microbial features may improve prediction accuracy.
Abstract
Background Alterations in the gut microbiota have been associated with a variety of psychiatric disorders, including major depressive disorder (MDD). However, the relationship between MDD and gut microbial communities remains incompletely understood. Most previous studies have primarily focused on gut bacteria, with relatively limited attention to other microbial components. Methods In this study, we analyzed gut microbial profiles from 36 patients with MDD and 36 healthy controls using metagenomic sequencing data. The MaAsLin2 algorithm was applied to identify potential microbial biomarkers associated with MDD. Results A total of 6 bacterial biomarkers and 7 viral biomarkers were identified. The models based on these features demonstrated strong predictive performance, with area under the curve (AUC) values of 0.891 for bacteria and 0.878 for viruses. Notably, the combined bacterial-viral model achieved an AUC of 0.946. These findings were further evaluated through external testing in two unrelated research cohorts. In the Shanxi cohort, the AUC values were 0.825 (bacteria), 0.803 (viruses), and 0.972 (combined model). In the Wuhan cohort, the AUC values were 0.683 (bacteria), 0.693 (viruses), and 0.784 (combined model). Conclusion In summary, our results highlight the potential of gut bacterial and viral biomarkers as candidate biomarkers and potential auxiliary tools for MDD assessment and suggest that integrating multi-domain microbial features may improve prediction accuracy.
PPD was associated with alterations in gut microbiota composition and exploratory circulating metabolite profiles, potentially involving lipid dysregulation, neuroinflammation, steroid-related metabolism, and neurotoxicity-related pathways.
Sheng-Xuan Li, Min Pi, Zhuo-Xin Yang et al.· Nutrients· 0 citations
Gut microbiota-targeted interventions are effective for alleviating depressive symptoms in adults with MDD-a finding supported by low-to-moderate certainty of evidence, but this finding should be interpreted with caution due to the limited certainty of evidence.
Shuo Jin, Chenming Li, Ni Sun et al.· Nutrition reviews· 0 citations
Current evidence suggests that functional gut microbiome dysregulation may represent a more reproducible biological feature of MDD than isolated taxonomic alterations alone, and large-scale longitudinal multi-omics studies using standardized methodologies are required.
Gulshat Dalibayeva, M. Goremykina, S. Kozhakhmetov et al.· Epidemiologia· 0 citations
This study provides the first data-driven evidence for a potential causal role of gut microbiota in the pathophysiology of depression in humans, and employs state-of-the-art causal inference tools within Judea Pearl's framework.
L. Fehse, A. H. Ribeiro, N. Winter et al.· Gut microbes· 0 citations
Gut microbiome provides a candidate approach for potential risk stratification in psychiatric populations, and MDD + RBD may represent a biologically distinct depression subtype associated with potential neurodegenerative risk.
Yuhua Yang, Ningning Li, Li Zhou et al.· Molecular Psychiatry· 0 citations
Ischemic stroke is associated with distinct gut microbial dysbiosis characterized by a pro-inflammatory, opportunistic pathogen-enriched, and butyrate-producer-depleted profile, and the gut microbiota may serve as a potential biomarker and therapeutic target in ischemic stroke.
Rong Tang, Ying Xu, Yu Zhou et al.· Frontiers in Cellular and In...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.